Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study
Spinal hemangioblastomas (sHB) are rare vascular tumors, with distinct clinical courses between von Hippel-Lindau (VHL)-associated and sporadic cases. The MIB-1 labeling index has been proposed as a surrogate marker for tumor proliferation, but its prognostic value remains unclear in this context. In this subgroup analysis from a multicenter retrospective study, we analyzed 116 primary sHB patients with available MIB-1 indices. Patients were stratified by VHL status. Statistical comparisons included ROC analyses for local progression-free survival (PFS) prediction and Kaplan-Meier survival curves for local PFS, stratified by a MIB-1 index cut-off derived from Youden's index. The MIB-1 index was significantly lower in VHL-associated tumors compared to sporadic ones (mean 2.17% vs. 3.02%, p = 0.008). In VHL-associated sHB, a higher MIB-1 index (≥ 2%) correlated with an increased risk of local tumor progression (AUC 0.74, 95% CI 0.49-0.98), whereas this was not observed in sporadic cases (AUC 0.56, 95% CI 0.23-0.88). Kaplan-Meier analysis showed that VHL patients with MIB-1 ≥ 2% had significantly shorter PFS (p = 0.05), while no significant association was found in sporadic tumors (p = 0.87). Our findings suggest that while VHL-associated sHB exhibit lower proliferative indices overall, elevated MIB-1 labeling indices might serve as a prognostic marker of shorter local PFS in this subgroup. In contrast, MIB-1 index appears to have limited prognostic relevance in sporadic sHB. These results highlight the importance of further molecular stratification and proliferation assessment in sHB to better inform clinical decision-making.
Authors
- Peter Vajkoczy (ORCID: https://orcid.org/0000-0003-4350-392X)
- Sandro M. Krieg (ORCID: https://orcid.org/0000-0003-4050-1531)
- Maximilian Middelkamp
- Roman Sankowski (ORCID: https://orcid.org/0000-0001-9215-8021)
- Martin Vychopen (ORCID: https://orcid.org/0000-0002-1794-0387)
- Erdem Güresir (ORCID: https://orcid.org/0000-0001-8319-0847)
- Lukas Klein (ORCID: https://orcid.org/0000-0002-5841-7621)
- Nicolas Neidert (ORCID: https://orcid.org/0000-0003-0299-1138)
- Vicki M. Butenschöen (ORCID: https://orcid.org/0000-0002-0421-7974)
- Romina Hohenhaus
- Bernhard Meyer (ORCID: https://orcid.org/0000-0001-6486-7955)
- Christine Steiert (ORCID: https://orcid.org/0000-0002-5662-5777)
- Jan‐Helge Klingler (ORCID: https://orcid.org/0000-0003-3469-9027)
- Obada Alhalabi
- Sebastian Siller (ORCID: https://orcid.org/0000-0002-5236-4397)
- Maria Wostrack (ORCID: https://orcid.org/0000-0001-6439-3665)
- Sven Oliver Eicker (ORCID: https://orcid.org/0000-0002-2648-5654)
- Marcus Czabanka (ORCID: https://orcid.org/0009-0006-6321-5086)
- Roberto Doria-Medina (ORCID: https://orcid.org/0000-0001-8180-8674)
- Philipp Dammann (ORCID: https://orcid.org/0000-0003-3618-5150)
- Marc Hohenhaus (ORCID: https://orcid.org/0000-0002-8743-3161)
- Ulrich Sure (ORCID: https://orcid.org/0000-0002-9073-1821)
- Steven D. Chang (ORCID: https://orcid.org/0000-0002-2530-2342)
- Tarık Tihan (ORCID: https://orcid.org/0000-0003-4551-2555)
- Johannes Wach (ORCID: https://orcid.org/0000-0002-4680-0412)
- Nils Ole Schmidt (ORCID: https://orcid.org/0000-0001-6910-8843)
- Alonso Barrantes‐Freer (ORCID: https://orcid.org/0000-0001-9988-4667)
- Alejandro N. Santos (ORCID: https://orcid.org/0000-0002-6616-5313)
- Julia Onken (ORCID: https://orcid.org/0000-0002-2859-4395)
- Tobias Pantel (ORCID: https://orcid.org/0009-0005-5575-3493)
- Tomasz Czernicki (ORCID: https://orcid.org/0000-0002-9991-1458)
- Claudius Thomé (ORCID: https://orcid.org/0000-0001-8568-9756)
- Jürgen Beck (ORCID: https://orcid.org/0000-0001-8794-9320)
- Przemysław Kunert (ORCID: https://orcid.org/0000-0002-0583-9505)
- Laurèl Rauschenbach (ORCID: https://orcid.org/0000-0001-8348-4298)
- Nikolaus Kögl (ORCID: https://orcid.org/0000-0003-2953-0753)
- Jae‐Hyun Park (ORCID: https://orcid.org/0000-0002-9858-2592)
- Fatma Kilinç (ORCID: https://orcid.org/0000-0002-3608-1338)
- Alim Emre Basaran
- Ahed H Kattaa
Institutions
- Goethe University Frankfurt (DE)
- Innsbruck Medical University (AT)
- University of Miami (US)
- Universität Hamburg (DE)
- University of Freiburg (DE)
- University of California, San Francisco (US)
- Heidelberg University (DE)
- Medical University of Warsaw (PL)
- University Medical Center Freiburg (DE)
- University Hospital Heidelberg (DE)
- TUM Klinikum (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Humboldt-Universität zu Berlin (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Essen University Hospital (DE)
- University Hospital Leipzig (DE)
- University Hospital Frankfurt (DE)
- Klinikum Passau (DE)
- Neurological Surgery (US)
- University of Regensburg (DE)
- Technical University of Munich (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
- Leipzig University (DE)
- Stanford University (US)
Publication Details
- Journal
- Acta Neuropathologica Communications
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1186/s40478-025-02202-w
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94